Curis, Inc. (CRIS) Financials

CRIS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 19.0 million 14.3 million
March 31, 2026 29.7 million 17.0 million
Dec. 31, 2025 20.0 million 14.5 million
Sept. 30, 2025 27.6 million 42.3 million

CRIS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.6 million ?
March 31, 2026 -9.0 million 575000
Dec. 31, 2025 -6.4 million 795000
Sept. 30, 2025 -5.6 million 924000

CRIS Net Income

No data available :(

CRIS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 5.6 million - -
March 31, 2026 15.0 million - 1.3 million
Dec. 31, 2025 5.1 million - 428000
Sept. 30, 2025 9.1 million - 2.0 million

CRIS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 2.1 million
March 31, 2026 968173
Dec. 31, 2025 787353
Sept. 30, 2025 784008

CRIS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 6.7 million 3.2 million -
March 31, 2026 - 6.4 million 5.1 million -
Dec. 31, 2025 - 5.8 million 2.9 million -
Sept. 30, 2025 - 6.4 million 3.7 million -

CRIS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 8000
March 31, 2026 - 8000
Dec. 31, 2025 1.1 million 36000
Sept. 30, 2025 3.2 million 15000

CRIS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CRIS

Price: $1.65

52 week price:
1.54
39.00

Earnings Per Share: -396.87 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 479800

Ebitda: -14.2 million

Market Capitalization: 4.4 million

Links: